SCIENTURE HOLDINGS, INC. Other Notes Payable, Noncurrent
SCIENTURE HOLDINGS, INC. (SCNX) had Other Notes Payable, Noncurrent of $9.57 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:OtherLongTermNotesPayable · last filed 2026-08-13
- 2026-06-30: Other Notes Payable, Noncurrent $9.57M.
- 2017-12-31: Other Notes Payable, Noncurrent $222.55K.
- 2017-09-30: Other Notes Payable, Noncurrent $222.55K.
- 2017-06-30: Other Notes Payable, Noncurrent $222.55K.
| Period end | Other Notes Payable, Noncurrent |
|---|---|
| 2026-06-30 | $9.57M 10-Q · filed 2026-08-13 |
| 2017-12-31 | $222.55K 10-K · filed 2018-03-02 |
| 2017-09-30 | $222.55K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $222.55K 10-Q · filed 2017-08-04 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |